Literature DB >> 26364992

The association between the Th-17 immune response and pulmonary complications in a trauma ICU population.

Travis L Holloway1, Meenakshi Rani1, Andrew P Cap2, Ronald M Stewart1, Martin G Schwacha3.   

Abstract

BACKGROUND: The overall immunopathology of the T-helper cell (Th)-17 immune response has been implicated in various inflammatory diseases including pulmonary inflammation; however its potential role in acute respiratory distress syndrome (ARDS) is not defined. This study aimed to evaluate the Th-17 response in bronchoalveolar lavage fluid (BALF) and blood and from trauma patients with pulmonary complications.
METHODS: A total of 21 severely injured intensive care unit (ICU) subjects, who were mechanically ventilated and undergoing bronchoscopy, were enrolled. BALF and blood were collected and analyzed for Th-1 (interferon [IFN]γ), Th-2 (interleukin [IL]-4, -10), Th-17 (IL-17A, -17F, -22, 23) and pro-inflammatory (IL-1β, IL-6, tumor necrosis factor [TNF]α) cytokine levels.
RESULTS: Significant levels of the Th-17 cytokines IL-17A, -17F and -21 and IL-6 (which can be classified as a Th-17 cytokine) were observed in the BALF of all subjects. There were no significant differences in Th-17 cytokines between those subjects with ARDS and those without, with the exception of plasma and BALF IL-6, which was markedly greater in ARDS subjects, as compared with controls and non-ARDS subjects.
CONCLUSIONS: Trauma patients with pulmonary complications exhibited a significant Th-17 response in the lung and blood, suggesting that this pro-inflammatory milieu may be a contributing factor to such complications.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute lung injury; Acute respiratory distress syndrome; IL-17; Inflammation; Injury

Mesh:

Substances:

Year:  2015        PMID: 26364992      PMCID: PMC4632975          DOI: 10.1016/j.cyto.2015.09.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

Review 1.  IL-17 family: cytokines, receptors and signaling.

Authors:  Chunfang Gu; Ling Wu; Xiaoxia Li
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

Review 2.  gammadelta T cells: an important source of IL-17.

Authors:  Christina L Roark; Philip L Simonian; Andrew P Fontenot; Willi K Born; Rebecca L O'Brien
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

3.  Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness.

Authors:  Rhonda H Wilson; Gregory S Whitehead; Hideki Nakano; Meghan E Free; Jay K Kolls; Donald N Cook
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

4.  Burn-induced alterations in toll-like receptor-mediated responses by bronchoalveolar lavage cells.

Authors:  Richard F Oppeltz; Meenakshi Rani; Qiong Zhang; Martin G Schwacha
Journal:  Cytokine       Date:  2011-06-21       Impact factor: 3.861

5.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

6.  Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone.

Authors:  Qing-hai You; Dan Zhang; Cheng-cheng Niu; Zhong-ming Zhu; Nan Wang; Yang Yue; Geng-yun Sun
Journal:  Cytokine       Date:  2014-01-25       Impact factor: 3.861

7.  Complication rates among trauma centers.

Authors:  Darwin N Ang; Frederick P Rivara; Avery Nathens; Gregory J Jurkovich; Ronald V Maier; Jin Wang; Ellen J MacKenzie
Journal:  J Am Coll Surg       Date:  2009-09-19       Impact factor: 6.113

8.  Clinical risks for development of the acute respiratory distress syndrome.

Authors:  L D Hudson; J A Milberg; D Anardi; R J Maunder
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834

View more
  6 in total

Review 1.  Insights into the immuno-pathogenesis of acute respiratory distress syndrome.

Authors:  Judith Ju Ming Wong; Jing Yao Leong; Jan Hau Lee; Salvatore Albani; Joo Guan Yeo
Journal:  Ann Transl Med       Date:  2019-10

2.  Toll-like receptor responses are suppressed in trauma ICU patients.

Authors:  Travis L Holloway; Susannah E Nicholson; Meenakshi Rani; Andrew P Cap; Martin G Schwacha
Journal:  J Surg Res       Date:  2016-06-25       Impact factor: 2.192

Review 3.  Complement After Trauma: Suturing Innate and Adaptive Immunity.

Authors:  Shinjini Chakraborty; Ebru Karasu; Markus Huber-Lang
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

4.  Relevant Cytokines in the Management of Community-Acquired Pneumonia.

Authors:  Adrian Rendon; Erick J Rendon-Ramirez; Adrian G Rosas-Taraco
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

Review 5.  Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review.

Authors:  Jorge Pérez-Galarza; César Prócel; Cristina Cañadas; Diana Aguirre; Ronny Pibaque; Ricardo Bedón; Fernando Sempértegui; Hemmo Drexhage; Lucy Baldeón
Journal:  Vaccines (Basel)       Date:  2021-01-29

Review 6.  Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.

Authors:  Hamed Fouladseresht; Atefe Ghamar Talepoor; Nahid Eskandari; Marzieh Norouzian; Behrooz Ghezelbash; Mohammad Reza Beyranvand; Seyed Aria Nejadghaderi; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.